Keywords: novartis, launches, sandostatin, lar, first, market, pharma

Novartis Launches Sandostatin LAR In First Market

Article | 18 December 1997

- Novartis Pharma AG has launched Sandostatin LAR (long-actingrepeatable) in Germany, its first market. The drug is a new once-monthly injectable ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Octreotide Acetate

Sandostatin

Octreotide Acetate Injection

Sandostatin LAR

Go to drug listing